Related content

Oral Administration of 17β-Estradiol Over 3 Months Without Progestin Co-Administration Does Not Improve Coronary Flow Reserve in Post-Menopausal Women: A Randomized Placebo-Controlled Cross-Over CMR Study

By Schwitter Juerg  

Journal of Cardiovascular Magnetic Resonance, Vol. 9, Iss. 4, 2007-07 ,pp. : 665-672

Informa Healthcare

Access to resources Recommend Favorite

Conversion of circulating estrone sulfate to 17β-estradiol by ovarian tumor tissue: A possible mechanism behind elevated circulating concentrations of 17β-estradiol in postmenopausal women with ovarian tumors

By Kirilovas Dmitrijus   Schedvins Kjell   Naessén Tord   Von Schoultz Bo   Carlström Kjell  

Gynecological Endocrinology, Vol. 23, Iss. 1, 2007-01 ,pp. : 25-28

Informa Healthcare

Access to resources Recommend Favorite

Body mass index is a major determinant of abdominal fat accumulation in pre-, peri- and post-menopausal women

By Cervellati Carlo   Pansini Francesco Saverio   Bonaccorsi Gloria   Pascale Giuliana   Bagni Bruno   Castaldini Cristina   Ferrazini Stefania   Ridolfi Francesca   Pedriali Mery   Guariento Angela   Bergamini Carlo  

Gynecological Endocrinology, Vol. 25, Iss. 6, 2009-06 ,pp. : 413-417

Informa Healthcare

Access to resources Recommend Favorite

Effects of tibolone and combined 17-estradiol and norethisterone acetate on serum C-reactive protein in healthy post-menopausal women: a randomized trial

By Garnero Patrick  

Human Reproduction, Vol. 17, Iss. 10, 2002-10 ,pp. : 2748-2753

Oxford University Press

Access to resources Recommend Favorite

A study of the control of climacteric symptoms in postmenopausal women following sequential regimens of 1mg 17β-estradiol and trimegestone compared with a regimen containing 1mg estradiol valerate and norethisterone over a 2-year period

By Pornel B   Spielmann D   Group The Trimegestone 302 Study  

Gynecological Endocrinology, Vol. 21, Iss. 2, 2005-08 ,pp. : 74-81

Informa Healthcare

Access to resources Recommend Favorite